To support the efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN developed the QIAstat-Dx Respiratory SARS-CoV-2 Panel. This version of our multiplex syndromic cartridge detects and differentiates* 21 respiratory targets, including SARS-CoV-2.
Visit www.qiagen.com/coronavirus to learn more about how QIAGEN solutions can be used in the fight against COVID-19, or get in touch to let us know how we can support your lab.
Multiplex syndromic testing rapidly and simultaneously surveys a large number of pathogens, giving you the answers you need when you need them. Check out our infographic and learn more about syndromic testing for respiratory disease on the QIAstat-Dx!